» Articles » PMID: 33433832

The Circular RNA CircSlc7a11 Promotes Bone Cancer Pain Pathogenesis in Rats by Modulating LLC-WRC 256 Cell Proliferation and Apoptosis

Overview
Publisher Springer
Specialty Biochemistry
Date 2021 Jan 12
PMID 33433832
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Treatment of bone cancer pain (BCP) caused by bone metastasis in advanced cancers remains a challenge in clinical oncology, and the underlying mechanisms of BCP are poorly understood. This study aimed to investigate the pathogenic roles of circular RNAs (circRNAs) in regulating cancer cell proliferation and BCP development. Eight differentially expressed circRNAs in the rat spinal cord were validated by agarose gel electrophoresis and Sanger sequencing. Expression of circRNAs and mRNAs was detected by quantitative RT-PCR. MTS assay and flow cytometry were performed to analyze cell proliferation and apoptosis, respectively. Differentially expressed mRNA profiles were characterized by deep RNA sequencing, hierarchical clustering, and functional categorization. The interactions among circRNAs, microRNAs (miRNAs), and mRNAs were predicted using TargetScan. Additionally, western blot was performed to determine the protein levels of Pax8, Isg15, and Cxcl10. Multiple circRNAs were differentially expressed in the spinal cords of BCP model rats; of these, circSlc7a11 showed the greatest increase in expression. The overexpression of circSlc7a11 significantly promoted cell proliferation and repressed apoptosis of LLC-WRC 256 and UMR-106 cells, whereas circSlc7a11 silencing produced the opposite effects. Altered expression of circSlc7a11 also induced substantial changes in the mRNA expression profiles of LLC-WRC 256 cells; these changes were linked to multiple apoptotic processes and signaling pathways, such as the chemokine signaling pathway, and formed a complex circRNA/miRNA/mRNA network. Additionally, Pax8, Isg15, and Cxc110 protein level in LLC-WRC 256 cells was consistent with the mRNA results. The circRNA circSlc7a11 regulates rat BCP development by modulating LLC-WRC 256 cell proliferation and apoptosis through multiple-signaling mechanisms.

Citing Articles

Si and Zn dual ions upregulate the osteogenic differentiation of mBMSCs: mRNA transcriptomic sequencing analysis.

Yuan X, Wu T, Lu T, Ye J J Mater Sci Mater Med. 2024; 35(1):54.

PMID: 39251504 PMC: 11383841. DOI: 10.1007/s10856-024-06825-8.


Role of circRNAs in regulating cell death in cancer: a comprehensive review.

Saadh M, Ehymayed H, Alazzawi T, Fahdil A, Athab Z, Yarmukhamedov B Cell Biochem Biophys. 2024; 83(1):109-133.

PMID: 39243349 DOI: 10.1007/s12013-024-01492-6.


Metformin relieves bone cancer pain by reducing TGFβRI-TRPV1 signaling in rats.

Zhou F, Qian H, Wang K, Gu Y, Liu P, Zhang L Heliyon. 2024; 10(15):e34991.

PMID: 39157315 PMC: 11328085. DOI: 10.1016/j.heliyon.2024.e34991.


Circular RNA circSLC7A11 contributes to progression and stemness of laryngeal squamous cell carcinoma via sponging miR-877-5p from LASP1.

Yu W, He X, Zhang C, Huang F Heliyon. 2023; 9(7):e18290.

PMID: 37539185 PMC: 10393633. DOI: 10.1016/j.heliyon.2023.e18290.


Role of hippocampal circKcnk9 in visceral hypersensitivity and anxiety comorbidity of irritable bowel syndrome.

Liu Y, Chen Z, Lin W, Zhou Y, Liu Z, Zhao R Front Cell Neurosci. 2022; 16:1010107.

PMID: 36467610 PMC: 9714028. DOI: 10.3389/fncel.2022.1010107.


References
1.
Mantyh P . Bone cancer pain: causes, consequences, and therapeutic opportunities. Pain. 2013; 154 Suppl 1:S54-S62. DOI: 10.1016/j.pain.2013.07.044. View

2.
Mantyh P . Bone cancer pain: from mechanism to therapy. Curr Opin Support Palliat Care. 2014; 8(2):83-90. PMC: 4068714. DOI: 10.1097/SPC.0000000000000048. View

3.
Sindhi V, Erdek M . Interventional treatments for metastatic bone cancer pain. Pain Manag. 2019; 9(3):307-315. DOI: 10.2217/pmt-2018-0073. View

4.
Guan X, Fu Q, Shi D, Bu H, Song Z, Xiong B . Activation of spinal chemokine receptor CXCR3 mediates bone cancer pain through an Akt-ERK crosstalk pathway in rats. Exp Neurol. 2014; 263:39-49. DOI: 10.1016/j.expneurol.2014.09.019. View

5.
Guo G, Gao F . CXCR3: latest evidence for the involvement of chemokine signaling in bone cancer pain. Exp Neurol. 2015; 265:176-9. DOI: 10.1016/j.expneurol.2015.02.003. View